Clinical research, Pharmacology, Clinical trial, Good clinical practice, Drug development, Drug discovery
‘It’s a transformation’: Researchers are taking DeepMind’s groundbreaking protein folding software to places few predicted
When Google and a University of Washington lab released open source software last year that could predict the structure of proteins with unprecedented accuracy, scientists almost universally hailed it as a breakthrough that could rapidly accelerate the pace of biological discovery and ...
‘It’s a transformation’: Researchers are taking DeepMind’s groundbreaking protein folding software to places few predicted
When Google and a University of Washington lab released open source software last year that could predict the structure of proteins with unprecedented accuracy, scientists almost ...
We are sorry, we could not find the related article
If you are curious about Biotech Essentials and Career and Jobs
Please click on:
Subscribe to Biotech Essentials - Career and Jobs
It’s Califf: Biden picks the former FDA commish to head back to the helm
Confirming one of the worst kept secrets in Washington, news reports are ricocheting through the Beltway that Robert Califf will be nominated later today to lead the FDA for a second time. ...
Covid-19 is forcing pharma to rethink clinical trials
Drug trials have become a casualty of Covid-19, but the pandemic is also prompting change
What's Next: Engaging HCPs in a Digital World #esante #hcsmeufr #digitalhealth
Ten years ago, fewer than half of physicians owned a smartphone. Tablets were even rarer and finding credible medical information on social media was next to i…
4 Life Science Trends To Pay Attention To in 2021
With COVID-19 having dominated the headlines in 2020, the coronavirus pandemic will inevitably continue to be the biggest story in 2021, but hopefully for more positive reasons. This year ...
Novartis CEO Who Wanted To Bring Tech Into Pharma Now Explains Why It's So Hard
We need to bring our best technology – biological and digital – and our most creative people together to work on this monumental challenge. One clear take-away from the Narasimhan ...
Digital therapeutics get first FDA clearance, Novartis focuses on digital after announcing job cuts and other Q4 pharma news
Also: The pharma industry continues to use digital technologies for R&D and diabetes management.
GlaxoSmithKline makes $300M investment in 23andMe, forms 50-50 R&D pact
GlaxoSmithKline has made a $300 million equity investment in 23andMe as part of a deal that pulls it close to the consumer genetics pioneer. The partners are contributing preclinical ...
Artificial Intelligence: A New Era of Data-Driven Medicine
Artificial Intelligence: A New Era of Data-Driven Medicine
Recon: Swiss Competition Authority Names Boehringer, 10 Others in Antitrust Probe; Roche Pays $200M to License Dicerna RNAi Drug
Welcome to Regulatory Reconnaissance, your daily regulatory news and intelligence briefing.
Transforming Clinical Trials with Real-World Evidence
Once a visionary ambition, synthetic control arms are poised to take off. Now is the time for pharma companies to identify opportunities and gain experience.
How to craft responsive clinical trials that are designed for success
Without the right design, right data and right decisions, idealised clinical trial plans cannot be translated into blueprints for robust studies.
Patients in the driving seat
Many pharma companies talk about the importance of involving patients in trial design – but what does this really mean?
Artificial intelligence in drug development predicted to grow: DIA-Tufts study
In which areas is artificial intelligence most mature? What are the challenges to widespread adoption? Tufts and DIA recently teamed up to explore these questions.